Top

Published in:

Open Access 01-11-2018 | Skin Cancer (T Ito, Section Editor)

Dermatoscopy of Neoplastic Skin Lesions: Recent Advances, Updates, and Revisions

Authors: Philipp Weber, MD, Philipp Tschandl, MD, PhD, Christoph Sinz, MD, Harald Kittler, MD

Published in: Current Treatment Options in Oncology | Issue 11/2018

Opinion statement

Dermatoscopy (dermoscopy) improves the diagnosis of benign and malignant cutaneous neoplasms in comparison with examination with the unaided eye and should be used routinely for all pigmented and non-pigmented cutaneous neoplasms. It is especially useful for the early stage of melanoma when melanoma-specific criteria are invisible to the unaided eye. Preselection by the unaided eye is therefore not recommended. The increased availability of polarized dermatoscopes, and the extended use of dermatoscopy in non-pigmented lesions led to the discovery of new criteria, and we recommend that lesions should be examined with polarized and non-polarized dermatoscopy. The “chaos and clues algorithm” is a good starting point for beginners because it is easy to use, accurate, and it works for all types of pigmented lesions not only for those melanocytic. Physicians, who use dermatoscopy routinely, should be aware of new clues for acral melanomas, nail matrix melanomas, melanoma in situ, and nodular melanoma. Dermatoscopy should also be used to distinguish between different subtypes of basal cell carcinoma and to discriminate highly from poorly differentiated squamous cell carcinomas to optimize therapy and management of non-melanoma skin cancer. One of the most exciting areas of research is the use of dermatoscopic images for machine learning and automated diagnosis. Convolutional neural networks trained with dermatoscopic images are able to diagnose pigmented lesions with the same accuracy as human experts. We humans should not be afraid of this new and exciting development because it will most likely lead to a peaceful and fruitful coexistence of human experts and decision support systems.

Argenziano G, Soyer HP. Dermoscopy of pigmented skin lesions—a valuable tool for early diagnosis of melanoma. Lancet Oncol. 2001;2(7):443–9.CrossRef

Argenziano G, Soyer HP, Chimenti S, Talamini R, Corona R, Sera F, et al. Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet. J Am Acad Dermatol. 2003;48(5):679–93. https://doi.org/10.1067/mjd.2003.281.CrossRefPubMed

Pehamberger H, Binder M, Steiner A, Wolff K. In vivo epiluminescence microscopy: improvement of early diagnosis of melanoma. J Invest Dermatol. 1993;100(3):356S–62S.CrossRef

•• Sinz C, Tschandl P, Rosendahl C, Akay BN, Argenziano G, Blum A, et al. Accuracy of dermatoscopy for the diagnosis of nonpigmented cancers of the skin. J Am Acad Dermatol. 2017;77(6):1100–9. https://doi.org/10.1016/j.jaad.2017.07.022 First study that demonstrates that dermatoscopy is superior to naked eye examination in non-pigmented lesions.CrossRefPubMed

Rigel DS. Malignant melanoma: perspectives on incidence and its effects on awareness, diagnosis, and treatment. CA Cancer J Clin. 1996;46(4):195–8.CrossRef

Rigel DS, Friedman RJ, Kopf AW. Lifetime risk for development of skin cancer in the U.S. population: current estimate is now 1 in 5. J Am Acad Dermatol. 1996;35(6):1012–3.CrossRef

Rigel DS, Friedman RJ, Kopf AW. The incidence of malignant melanoma in the United States: issues as we approach the 21st century. J Am Acad Dermatol. 1996;34(5 Pt 1):839–47.CrossRef

Burton RC. Malignant melanoma in the year 2000. CA Cancer J Clin. 2000;50(4):209–13.CrossRef

Rosendahl C, Williams G, Eley D, Wilson T, Canning G, Keir J, et al. The impact of subspecialization and dermatoscopy use on accuracy of melanoma diagnosis among primary care doctors in Australia. J Am Acad Dermatol. 2012;67(5):846–52. https://doi.org/10.1016/j.jaad.2011.12.030.CrossRefPubMed

10.

Kittler H, Pehamberger H, Wolff K, Binder M. Diagnostic accuracy of dermoscopy. Lancet Oncol. 2002;3(3):159–65.CrossRef

11.

Vestergaard ME, Macaskill P, Holt PE, Menzies SW. Dermoscopy compared with naked eye examination for the diagnosis of primary melanoma: a meta-analysis of studies performed in a clinical setting. Br J Dermatol. 2008;159(3):669–76. https://doi.org/10.1111/j.1365-2133.2008.08713.x.CrossRefPubMed

12.

Mayer J. Systematic review of the diagnostic accuracy of dermatoscopy in detecting malignant melanoma. Med J Aust. 1997;167(4):206–10.PubMed

13.

Bafounta ML, Beauchet A, Aegerter P, Saiag P. Is dermoscopy (epiluminescence microscopy) useful for the diagnosis of melanoma? Results of a meta-analysis using techniques adapted to the evaluation of diagnostic tests. Arch Dermatol. 2001;137(10):1343–50.CrossRef

14.

Rosendahl C, Cameron A, McColl I, Wilkinson D. Dermatoscopy in routine practice—‘chaos and clues’. Aust Fam Physician. 2012;41(7):482–7.PubMed

15.

Jaimes N, Marghoob AA, Rabinovitz H, Braun RP, Cameron A, Rosendahl C, et al. Clinical and dermoscopic characteristics of melanomas on nonfacial chronically sun-damaged skin. J Am Acad Dermatol. 2015;72(6):1027–35. https://doi.org/10.1016/j.jaad.2015.02.1117.CrossRefPubMed

16.

Carrera C, Marchetti MA, Dusza SW, Argenziano G, Braun RP, Halpern AC, et al. Validity and reliability of dermoscopic criteria used to differentiate nevi from melanoma: a web-based international dermoscopy society study. JAMA Dermatol. 2016;152(7):798–806. https://doi.org/10.1001/jamadermatol.2016.0624.CrossRefPubMedPubMedCentral

17.

Ramji R, Valdes-Gonzalez G, Oakley A, Rademaker M. Dermoscopic ‘chaos and clues’ in the diagnosis of melanoma in situ. Aust J Dermatol. 2017;59:201–5. https://doi.org/10.1111/ajd.12740.CrossRef

18.

•• Lallas A, Longo C, Manfredini M, Benati E, Babino G, Chinazzo C, et al. Accuracy of dermoscopic criteria for the diagnosis of melanoma in situ. JAMA Dermatol. 2018;154(4):414–9. https://doi.org/10.1001/jamadermatol.2017.6447 In depth analysis of melanoma in situ in comparison to important mimics.CrossRefPubMed

19.

Shaikh WR, Xiong M, Weinstock MA. The contribution of nodular subtype to melanoma mortality in the United States, 1978 to 2007. Arch Dermatol. 2012;148(1):30–6. https://doi.org/10.1001/archdermatol.2011.264.CrossRefPubMed

20.

•• Pizzichetta MA, Kittler H, Stanganelli I, Bono R, Cavicchini S, De Giorgi V, et al. Pigmented nodular melanoma: the predictive value of dermoscopic features using multivariate analysis. Br J Dermatol. 2015;173(1):106–14. https://doi.org/10.1111/bjd.13861 Recent revision of criteria for nodular melanoma in a large cohort.CrossRefPubMed

21.

Kelly JW. Nodular melanoma: how current approaches to early detection are failing. J Drugs Dermatol. 2005;4(6):790–3.PubMed

22.

Menzies SW, Moloney FJ, Byth K, Avramidis M, Argenziano G, Zalaudek I, et al. Dermoscopic evaluation of nodular melanoma. JAMA Dermatol. 2013;149(6):699–709. https://doi.org/10.1001/jamadermatol.2013.2466.CrossRefPubMed

23.

Seiji M, Takematsu H, Hosokawa M, Obata M, Tomita Y, Kato T, et al. Acral melanoma in Japan. J Invest Dermatol. 1983;80 Suppl:56s–60s.CrossRef

24.

Byrd KM, Wilson DC, Hoyler SS, Peck GL. Advanced presentation of melanoma in African Americans. J Am Acad Dermatol. 2004;50(1):21–4; discussion 142–3. https://doi.org/10.1016/S0190.CrossRefPubMed

25.

Cress RD, Holly EA. Incidence of cutaneous melanoma among non-Hispanic whites, Hispanics, Asians, and blacks: an analysis of California cancer registry data, 1988-93. Cancer Causes Control. 1997;8(2):246–52.CrossRef

26.

Reintgen DS, McCarty KM Jr, Cox E, Seigler HF. Malignant melanoma in black American and white American populations. A comparative review. JAMA. 1982;248(15):1856–9.CrossRef

27.

Stevens NG, Liff JM, Weiss NS. Plantar melanoma: is the incidence of melanoma of the sole of the foot really higher in blacks than whites? Int J Cancer. 1990;45(4):691–3.CrossRef

28.

Saida T, Miyazaki A, Oguchi S, Ishihara Y, Yamazaki Y, Murase S, et al. Significance of dermoscopic patterns in detecting malignant melanoma on acral volar skin: results of a multicenter study in Japan. Arch Dermatol. 2004;140(10):1233–8. https://doi.org/10.1001/archderm.140.10.1233.CrossRefPubMed

29.

Braun RP, Thomas L, Dusza SW, Gaide O, Menzies S, Dalle S, et al. Dermoscopy of acral melanoma: a multicenter study on behalf of the international dermoscopy society. Dermatology. 2013;227(4):373–80. https://doi.org/10.1159/000356178.CrossRefPubMed

30.

•• Lallas A, Kyrgidis A, Koga H, Moscarella E, Tschandl P, Apalla Z, et al. The BRAAFF checklist: a new dermoscopic algorithm for diagnosing acral melanoma. Br J Dermatol. 2015;173(4):1041–9. https://doi.org/10.1111/bjd.14045 Recent revision of criteria of acral melanoma and introduction of a new algorithm.CrossRefPubMed

31.

Stolz W, Schiffner R, Burgdorf WH. Dermatoscopy for facial pigmented skin lesions. Clin Dermatol. 2002;20(3):276–8.CrossRef

32.

Tschandl P, Rosendahl C, Kittler H. Dermatoscopy of flat pigmented facial lesions. J Eur Acad Dermatol Venereol. 2015;29(1):120–7. https://doi.org/10.1111/jdv.12483.CrossRefPubMed

33.

Akay BN, Kocyigit P, Heper AO, Erdem C. Dermatoscopy of flat pigmented facial lesions: diagnostic challenge between pigmented actinic keratosis and lentigo maligna. Br J Dermatol. 2010;163(6):1212–7. https://doi.org/10.1111/j.1365-2133.2010.10025.x.CrossRefPubMed

34.

Lallas A, Tschandl P, Kyrgidis A, Stolz W, Rabinovitz H, Cameron A, et al. Dermoscopic clues to differentiate facial lentigo maligna from pigmented actinic keratosis. Br J Dermatol. 2016;174(5):1079–85. https://doi.org/10.1111/bjd.14355.CrossRefPubMed

35.

•• Tschandl P, Gambardella A, Boespflug A, Deinlein T, de Giorgi V, Kittler H, et al. Seven non-melanoma features to rule out facial melanoma. Acta Derm Venereol. 2017;97(10):1219–24. https://doi.org/10.2340/00015555-2759 Innovative approach for facial lesions.CrossRefPubMed

36.

Thomas L, Dalle S. Dermoscopy provides useful information for the management of melanonychia striata. Dermatol Ther. 2007;20(1):3–10. https://doi.org/10.1111/j.1529-8019.2007.00106.x.CrossRefPubMed

37.

•• Benati E, Ribero S, Longo C, Piana S, Puig S, Carrera C, et al. Clinical and dermoscopic clues to differentiate pigmented nail bands: an International Dermoscopy Society study. J Eur Acad Dermatol Venereol. 2017;31(4):732–6. https://doi.org/10.1111/jdv.13991 Recent large study on nail pigmentations.CrossRefPubMed

38.

Ohn J, Jo G, Cho Y, Sheu SL, Cho KH, Mun JH. Assessment of a predictive scoring model for dermoscopy of subungual melanoma in situ. JAMA Dermatol. 2018;154(8):890–6. https://doi.org/10.1001/jamadermatol.2018.1372.CrossRefPubMed

39.

Ohn J, Choe YS, Mun JH. Dermoscopic features of nail matrix nevus (NMN) in adults and children: a comparative analysis. J Am Acad Dermatol. 2016;75(3):535–40. https://doi.org/10.1016/j.jaad.2016.03.043.CrossRefPubMed

40.

Karimkhani C, Boyers LN, Dellavalle RP, Weinstock MA. It’s time for “keratinocyte carcinoma” to replace the term “nonmelanoma skin cancer”. J Am Acad Dermatol. 2015;72(1):186–7. https://doi.org/10.1016/j.jaad.2014.09.036.CrossRefPubMed

41.

Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol. 2012;166(5):1069–80. https://doi.org/10.1111/j.1365-2133.2012.10830.x.CrossRefPubMed

42.

Reinau D, Surber C, Jick SS, Meier CR. Epidemiology of basal cell carcinoma in the United Kingdom: incidence, lifestyle factors, and comorbidities. Br J Cancer 2014;111(1):203–206. doi:https://doi.org/10.1038/bjc.2014.265.CrossRef

43.

Wu S, Han J, Li WQ, Li T, Qureshi AA. Basal-cell carcinoma incidence and associated risk factors in U.S. women and men. Am J Epidemiol. 2013;178(6):890–7. https://doi.org/10.1093/aje/kwt073.CrossRefPubMedPubMedCentral

44.

Koh D, Wang H, Lee J, Chia KS, Lee HP, Goh CL. Basal cell carcinoma, squamous cell carcinoma and melanoma of the skin: analysis of the Singapore Cancer Registry data 1968-97. Br J Dermatol. 2003;148(6):1161–6.CrossRef

45.

Que SKT, Zwald FO, Schmults CD. Cutaneous squamous cell carcinoma: Management of advanced and high-stage tumors. J Am Acad Dermatol. 2018;78(2):249–61. https://doi.org/10.1016/j.jaad.2017.08.058.CrossRefPubMed

46.

Karia PS, Han J, Schmults CD. Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012. J Am Acad Dermatol. 2013;68(6):957–66. https://doi.org/10.1016/j.jaad.2012.11.037.CrossRefPubMed

47.

Lallas A, Apalla Z, Argenziano G, Longo C, Moscarella E, Specchio F, et al. The dermatoscopic universe of basal cell carcinoma. Dermatol Pract Concept. 2014;4(3):11–24. https://doi.org/10.5826/dpc.0403a02.CrossRefPubMedPubMedCentral

48.

•• Navarrete-Dechent C, Bajaj S, Marchetti MA, Rabinovitz H, Dusza SW, Marghoob AA. Association of shiny white blotches and strands with nonpigmented basal cell carcinoma: evaluation of an additional dermoscopic diagnostic criterion. JAMA Dermatol. 2016;152(5):546–52. https://doi.org/10.1001/jamadermatol.2015.5731 In depth revision of white structures in basal cell carcinoma.CrossRefPubMedPubMedCentral

49.

Menzies SW, Westerhoff K, Rabinovitz H, Kopf AW, McCarthy WH, Katz B. Surface microscopy of pigmented basal cell carcinoma. Arch Dermatol. 2000;136(8):1012–6.CrossRef

50.

Lallas A, Tzellos T, Kyrgidis A, Apalla Z, Zalaudek I, Karatolias A, et al. Accuracy of dermoscopic criteria for discriminating superficial from other subtypes of basal cell carcinoma. J Am Acad Dermatol. 2014;70(2):303–11. https://doi.org/10.1016/j.jaad.2013.10.003.CrossRefPubMed

51.

Ahnlide I, Zalaudek I, Nilsson F, Bjellerup M, Nielsen K. Preoperative prediction of histopathological outcome in basal cell carcinoma: flat surface and multiple small erosions predict superficial basal cell carcinoma in lighter skin types. Br J Dermatol. 2016;175(4):751–61. https://doi.org/10.1111/bjd.14499.CrossRefPubMed

52.

Emiroglu N, Cengiz FP, Kemeriz F. The relation between dermoscopy and histopathology of basal cell carcinoma. An Bras Dermatol. 2015;90(3):351–6. https://doi.org/10.1590/abd1806-4841.20153446.CrossRefPubMedPubMedCentral

53.

Zalaudek I, Kreusch J, Giacomel J, Ferrara G, Catricala C, Argenziano G. How to diagnose nonpigmented skin tumors: a review of vascular structures seen with dermoscopy: part II. Nonmelanocytic skin tumors. J Am Acad Dermatol. 2010;63(3):377–86; quiz 87–8. https://doi.org/10.1016/j.jaad.2009.11.697.CrossRefPubMed

54.

Pyne JH, Fishburn P, Dicker A, David M. Infiltrating basal cell carcinoma: a stellate peri-tumor dermatoscopy pattern as a clue to diagnosis. Dermatol Pract Concept. 2015;5(2):21–6. https://doi.org/10.5826/dpc.0502a02.CrossRefPubMedPubMedCentral

55.

de Faria J. Basal cell carcinoma of the skin with areas of squamous cell carcinoma: a basosquamous cell carcinoma? J Clin Pathol. 1985;38(11):1273–7.CrossRef

56.

Garcia C, Poletti E, Crowson AN. Basosquamous carcinoma. J Am Acad Dermatol. 2009;60(1):137–43. https://doi.org/10.1016/j.jaad.2008.09.036.CrossRefPubMed

57.

Akay BN, Saral S, Heper AO, Erdem C, Rosendahl C. Basosquamous carcinoma: dermoscopic clues to diagnosis. J Dermatol. 2017;44(2):127–34. https://doi.org/10.1111/1346-8138.13563.CrossRefPubMed

58.

Hurt MA. Keratoacanthoma vs. squamous cell carcinoma in contrast with keratoacanthoma is squamous cell carcinoma. J Cutan Pathol. 2004;31(3):291–2. https://doi.org/10.1111/j.0303-6987.2004.0150a.x.CrossRefPubMed

59.

Weedon D, Malo J, Brooks D, Williamson R. Keratoacanthoma: is it really a variant of squamous cell carcinoma? ANZ J Surg. 2010;80(3):129–30. https://doi.org/10.1111/j.1445-2197.2010.05219.x.CrossRefPubMed

60.

Rosendahl C, Cameron A, Argenziano G, Zalaudek I, Tschandl P, Kittler H. Dermoscopy of squamous cell carcinoma and keratoacanthoma. Arch Dermatol. 2012;148(12):1386–92. https://doi.org/10.1001/archdermatol.2012.2974.CrossRefPubMed

61.

•• Lallas A, Pyne J, Kyrgidis A, Andreani S, Argenziano G, Cavaller A, et al. The clinical and dermoscopic features of invasive cutaneous squamous cell carcinoma depend on the histopathological grade of differentiation. Br J Dermatol. 2015;172(5):1308–15. https://doi.org/10.1111/bjd.13510 First study on dermatoscopic criteria of highly and poorly differentiated SCC.CrossRefPubMed

62.

Binder M, Kittler H, Seeber A, Steiner A, Pehamberger H, Wolff K. Epiluminescence microscopy-based classification of pigmented skin lesions using computerized image analysis and an artificial neural network. Melanoma Res. 1998;8(3):261–6.CrossRef

63.

Binder M, Steiner A, Schwarz M, Knollmayer S, Wolff K, Pehamberger H. Application of an artificial neural network in epiluminescence microscopy pattern analysis of pigmented skin lesions: a pilot study. Br J Dermatol. 1994;130(4):460–5.CrossRef

64.

Rajpara SM, Botello AP, Townend J, Ormerod AD. Systematic review of dermoscopy and digital dermoscopy/ artificial intelligence for the diagnosis of melanoma. Br J Dermatol. 2009;161(3):591–604. https://doi.org/10.1111/j.1365-2133.2009.09093.x.CrossRefPubMed

65.

Russakovsky O, Deng J, Su H, Krause J, Satheesh S, Ma S, et al. ImageNet large scale visual recognition challenge. Int J Comput Vis. 2015;115(3):211–52. https://doi.org/10.1007/s11263-015-0816-y.CrossRef

66.

Tschandl P, Kittler H, Argenziano G. A pretrained neural network shows similar diagnostic accuracy to medical students in categorizing dermatoscopic images after comparable training conditions. Br J Dermatol. 2017;177(3):867–9. https://doi.org/10.1111/bjd.15695.CrossRefPubMed

67.

Marchetti MA, NCF C, Dusza SW, Gutman DA, Helba B, Kalloo A, et al. Results of the 2016 international skin imaging collaboration international symposium on biomedical imaging challenge: comparison of the accuracy of computer algorithms to dermatologists for the diagnosis of melanoma from dermoscopic images. J Am Acad Dermatol. 2018;78(2):270–277.e1. https://doi.org/10.1016/j.jaad.2017.08.016.CrossRefPubMed

68.

Dreiseitl S, Binder M, Vinterbo S, Kittler H. Applying a decision support system in clinical practice: results from melanoma diagnosis. AMIA Ann Symp Proc. 2007:191–5.

69.

Rosendahl C, Tschandl P, Cameron A, Kittler H. Diagnostic accuracy of dermatoscopy for melanocytic and nonmelanocytic pigmented lesions. J Am Acad Dermatol. 2011;64(6):1068–73. https://doi.org/10.1016/j.jaad.2010.03.039.CrossRefPubMed

70.

•• Tschandl P, Rosendahl C, Kittler H. The HAM10000 dataset, a large collection of multi-source dermatoscopic images of common pigmented skin lesions. Scientific Data. 2018;5:180161. https://doi.org/10.1038/sdata.2018.161 Description of large benchmark dataset of dermatoscopic images.CrossRefPubMedPubMedCentral

Title: Dermatoscopy of Neoplastic Skin Lesions: Recent Advances, Updates, and Revisions
Authors: Philipp Weber, MD
Philipp Tschandl, MD, PhD
Christoph Sinz, MD
Harald Kittler, MD
Publication date: 01-11-2018
Publisher: Springer US
Published in: Current Treatment Options in Oncology / Issue 11/2018
Print ISSN: 1527-2729
Electronic ISSN: 1534-6277
DOI: https://doi.org/10.1007/s11864-018-0573-6

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Opinion statement

Please log in to get access to this content

Other articles of this Issue 11/2018

Sentinel Lymph Node Biopsy and Completion Lymph Node Dissection for Melanoma

Therapeutic Strategies in EGFR Mutant Non-Small Cell Lung Cancer

Low-Grade Serous Ovarian Cancer: Current Treatment Paradigms and Future Directions

Immunotherapy for Brain Tumors

Immunotherapy for Merkel Cell Carcinoma

Central Nervous System Prophylaxis Strategies in Diffuse Large B Cell Lymphoma

Keynote webinar | Spotlight on antibody–drug conjugates in cancer